Tech Company Financing Transactions
Senhwa Biosciences Funding Round
Senhwa Biosciences, based in New Taipei City, secured $16 million in investment from Global Emerging Markets.
Transaction Overview
Company Name
Announced On
4/14/2026
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This partnership highlights growing international investors' confidence in Senhwa's innovative R&D capabilities and its differentiated approach to integrating artificial intelligence into the development of its core assets.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10F, No. 225, Sec. 3, Peihsin Rd., Hsintien Dist.
New Taipei City, 23143
Taiwan
New Taipei City, 23143
Taiwan
Phone
Website
Email Address
Overview
Senhwa Biosciences Inc. was established in 2012 and listed on the Taipei Exchange (TPEx) on April 24, 2017. The company aims to transform the model for new drug development by focusing on human efficacy. Senhwa believes that its dedication to science and rigorous processes will enable Senhwa to achieve remarkable milestones.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Benny Hu
Chief Financial Officer
Sarah Chang
Chief Medical Officer
Jason Huang
VP - Bus. Development
Taylor Hsu
VP - R & D
Chen-Fu Liu
Browse more venture capital transactions:
Prev: 4/14/2026: Stegra venture capital transaction
Next: 4/14/2026: Calyxo venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs